Jon P Stonehouse Receives Stock Award at Biocryst Pharmaceuticals Inc (BCRX) — SEC Form 4, Sep 02, 2026

SEC Form 4 · No Market Transaction
Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner
Director
TXN 2026-08-31 · FILED 2026-09-02
Equity Position 1.42M sh 1,419,775 → 1,420,419
Equity Change +0.1% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-09-02
Report Date
2026-09-02
Accession No.
0000882796-26-000065
Accepted At
2026-09-02 20:16 UTC
Reporting Owner
Name Relationship
Jon P Stonehouse CIK 0001385496
Director
Jon P Stonehouse at Biocryst Pharmaceuticals Inc Full insider history
Bought (12 mo) —
Sold (12 mo) —
More from this insider at Biocryst Pharmaceuticals Inc
2026-06-15 Award — View
2026-06-02 Award — View
2026-03-03 Exercise — View
2025-12-23 - — View
2025-12-19 Gift/Other — View
All filings by this insider at Biocryst Pharmaceuticals Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2026-08-31 A - Award/Grant 644 A $9.70 +$6,247 1,340,419 Direct
Non-Derivative Holdings
Title Shares Held Ownership
Common Stock 40,000 Indirect By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust
Common Stock 40,000 Indirect By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust
Footnotes (1)
F1
Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $12,500. Show more
5%+ Holders · 13D/G 4 filers
Other insiders at Biocryst Pharmaceuticals Inc
All Biocryst Pharmaceuticals Inc insider activity
GET /v1/forms/4/0000882796-26-000065 API docs
View Original SEC Filing